A drug that improves levels of “good” cholesterol may not be beneficial for obese individuals, Vanderbilt researchers have discovered.
It might be possible to generate a “metabolically healthy” state of obesity by targeting signaling pathways that improve insulin sensitivity.
Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol.
Accessibility Tools